Trends Report

Embrace Value-Based Pharmaceutical Contracting Or Risk Losing Buyers To Competitors

November 26th, 2019


Drug manufacturers are beginning to explore new contract models to support industrywide calls for value-based-care reform. New trends in value-based pharmaceutical contracting are emerging. Win-win negotiations require the right drug, the right outcome, and the right data sharing agreement. Cardiology, infectious disease, and oncology are the leading high-impact areas where health insurers are finding success.

Want to read the full report?

This report is available for individual purchase ($1495).

Forrester helps business and technology leaders use customer obsession to accelerate growth. That means empowering you to put the customer at the center of everything you do: your leadership strategy, and operations. Becoming a customer-obsessed organization requires change — it requires being bold. We give business and technology leaders the confidence to put bold into action, shaping and guiding how to navigate today's unprecedented change in order to succeed.